{"id":150,"date":"2020-12-14T13:36:23","date_gmt":"2020-12-14T12:36:23","guid":{"rendered":"https:\/\/onetech.dev\/covid\/?page_id=150"},"modified":"2026-04-22T15:27:58","modified_gmt":"2026-04-22T14:27:58","slug":"urologique","status":"publish","type":"page","link":"https:\/\/onetech.dev\/covid\/urologique","title":{"rendered":"Urologique"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container type_sticky\"><div class=\"vc_column-inner\" style=\"top:180px\"><div class=\"w-image us_custom_fb33871a us_animate_this has_height align_center\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"900\" height=\"127\" src=\"https:\/\/onetech.dev\/covid\/data\/irc_logo.png\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/onetech.dev\/covid\/data\/irc_logo.png 900w, https:\/\/onetech.dev\/covid\/data\/irc_logo-300x42.png 300w, https:\/\/onetech.dev\/covid\/data\/irc_logo-150x21.png 150w\" sizes=\"auto, (max-width: 900px) 100vw, 900px\" \/><\/div><\/div><div class=\"ult-spacer spacer-69f410146d9f3\" data-id=\"69f410146d9f3\" data-height=\"35\" data-height-mobile=\"35\" data-height-tab=\"35\" data-height-tab-portrait=\"\" data-height-mobile-landscape=\"\" style=\"clear:both;display:block;\"><\/div><h3 class=\"w-text us_custom_7ccf62ca has_text_color\"><span class=\"w-text-h\"><span class=\"w-text-value\">RECOMMANDATIONS G\u00c9N\u00c9RALES<\/span><\/span><\/h3><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"g-cols wpb_row via_grid cols_2-1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:3rem;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"aio-icon-component    style_2\"><a class=\"aio-icon-box-link\" ><div id=\"Info-box-wrap-2166\" class=\"aio-icon-box left-icon\" style=\"\"  ><div class=\"aio-icon-left\"><div class=\"ult-just-icon-wrapper  \"><div class=\"align-icon\" style=\"text-align:center;\">\n<div class=\"aio-icon-img \" style=\"font-size:50px;background:#03254C;border-style:solid;border-color:#03254C;border-width:1px;padding:20px;border-radius:500px;display:inline-block;\" >\n\t<img decoding=\"async\" class=\"img-icon\" alt=\"null\" src=\"https:\/\/onetech.dev\/covid\/data\/kidney.png\"\/>\n<\/div><\/div><\/div><\/div><div class=\"aio-ibd-block\"><div class=\"aio-icon-header\" ><h6 class=\"aio-icon-title ult-responsive\"  data-ultimate-target='#Info-box-wrap-2166 .aio-icon-title'  data-responsive-json-new='{\"font-size\":\"\",\"line-height\":\"\"}'  style=\"font-weight:bold;color:#03254C;\">Urologique<\/h6><\/div> <!-- header --><\/div> <!-- aio-ibd-block --><\/div> <!-- aio-icon-box --><\/a><\/div> <!-- aio-icon-component --><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-btn-wrapper align_right\"><a class=\"w-btn us-btn-style_1 icon_atleft\" href=\"https:\/\/onetech.dev\/covid\/\"><i class=\"far fa-backward\"><\/i><span class=\"w-btn-label\">Retour<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"ult-spacer spacer-69f410146e81e\" data-id=\"69f410146e81e\" data-height=\"25\" data-height-mobile=\"25\" data-height-tab=\"25\" data-height-tab-portrait=\"\" data-height-mobile-landscape=\"\" style=\"clear:both;display:block;\"><\/div><div class=\"g-cols wpb_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:3rem;\"><div class=\"wpb_column vc_column_container us_custom_7e20fa79 us_animate_this\"><div class=\"vc_column-inner\"><div class=\"w-tabs us_custom_064d3121 style_default switch_click accordion has_scrolling\" style=\"--sections-title-size:18px\"><div class=\"w-tabs-sections titles-align_none icon_chevron cpos_right\"><div class=\"w-tabs-section active\" id=\"n3a7\"><button class=\"w-tabs-section-header active\" aria-controls=\"content-n3a7\" aria-expanded=\"true\"><div class=\"w-tabs-section-title\">1) Cancer de prostate<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content us_custom_ea76afbe\" id=\"content-n3a7\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p style=\"text-align: justify;\"><strong>a. Cancer de prostate localis\u00e9\u00a0<\/strong><\/p>\n<p style=\"text-align: justify;\">&#8211; Bas risque : surveillance active<\/p>\n<p style=\"text-align: justify;\">&#8211; Risque interm\u00e9diaire :<\/p>\n<ul style=\"text-align: justify;\">\n<li>Si indication de radioth\u00e9rapie :<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>Strat\u00e9gie d\u2019attente par hormonoth\u00e9rapie n\u00e9o-adjuvante \u00e0 base d\u2019analogues LH-RH pendant 3 mois<\/li>\n<li>Si l\u2019hormonoth\u00e9rapie n\u00e9o-adjuvante a d\u00e9j\u00e0 \u00e9t\u00e9 administr\u00e9e : r\u00e9aliser une radioth\u00e9rapie hypofractionn\u00e9e (60 Gy en 20 s\u00e9ances)\n<ul>\n<li>Si indication de prostatectomie : la diff\u00e9rer au maximum par surveillance active<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>Haut risque :\n<ul>\n<li>Privil\u00e9gier un traitement par hormono-radioth\u00e9rapie :<\/li>\n<li>Strat\u00e9gie d\u2019attente par hormonoth\u00e9rapie n\u00e9o-adjuvante \u00e0 base d\u2019analogues LH-RH pendant 6 mois<\/li>\n<li>Si l\u2019hormonoth\u00e9rapie n\u00e9o-adjuvante a d\u00e9j\u00e0 \u00e9t\u00e9 administr\u00e9e : r\u00e9aliser une radioth\u00e9rapie hypofractionn\u00e9e (60 Gy en 20 s\u00e9ances)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>b. Cancer de prostate m\u00e9tastatique<\/strong><\/p>\n<p style=\"text-align: justify;\">&#8211; \u00a0\u00a0Dans le cancer de prostate hormono-naif :<\/p>\n<ul style=\"text-align: justify;\">\n<li>Bas volume : castration par analogues LH-RH, diff\u00e9rer la radioth\u00e9rapie sur la prostate<\/li>\n<li>Haut volume :<\/li>\n<li>Privil\u00e9gier l\u2019hormonoth\u00e9rapie de 2<sup>\u00e8me<\/sup>g\u00e9n\u00e9ration par rapport \u00e0 la chimioth\u00e9rapie<\/li>\n<li>Si non-accessibilit\u00e9 aux hormonoth\u00e9rapies de 2<sup>\u00e8me<\/sup>g\u00e9n\u00e9ration, prescrire le docetaxel en association aux G-CSF et sans corticoth\u00e9rapie en continu<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&#8211; \u00a0Dans le cancer de prostate r\u00e9sistant \u00e0 la castration:<\/p>\n<ul>\n<li style=\"text-align: justify;\">Privil\u00e9gier l\u2019hormonoth\u00e9rapie de 2<sup>\u00e8me<\/sup>g\u00e9n\u00e9ration par rapport \u00e0 la chimioth\u00e9rapie si non re\u00e7ue en phase hormono-naive<\/li>\n<li style=\"text-align: justify;\">Si indication de chimioth\u00e9rapie : utiliser les G-CSF, pas de corticoth\u00e9rapie en continu<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"j57d\"><button class=\"w-tabs-section-header\" aria-controls=\"content-j57d\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">2) Cancer de la vessie<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content us_custom_71d3e3d1\" id=\"content-j57d\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p style=\"text-align: justify;\"><strong>a. Tumeur infiltrant le muscle v\u00e9sical localis\u00e9e<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Privil\u00e9gier la cystectomie en premi\u00e8re intension<\/li>\n<li>En situation adjuvante ou n\u00e9o-adjuvante : privil\u00e9gier le protocole gemcitabine et cisplatine avec G-CSF par rapport au protocole MVAC intensifi\u00e9.<\/li>\n<li>Si la cystectomie est contre-indique\u0301e : privile\u0301gier les sche\u0301mas courts de radiothe\u0301rapie (55 Gy\/20 se\u0301ances)<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>b. Tumeur infiltrant le muscle v\u00e9sical m\u00e9tastatique<\/strong><\/p>\n<p style=\"text-align: justify;\">Privil\u00e9gier le protocole gemcitabine et cisplatine avec G-CSF par rapport au protocole MVAC intensifi\u00e9<\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"u804\"><button class=\"w-tabs-section-header\" aria-controls=\"content-u804\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">3) Tumeurs germinales du testicule<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content us_custom_71d3e3d1\" id=\"content-u804\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p style=\"text-align: justify;\">Maintenir l\u2019orchidectomie dans les d\u00e9lais habituels<\/p>\n<p style=\"text-align: justify;\"><strong>a. Tumeurs germinales du testicule de stade I<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\u00a0 \u00a0 \u00a0 Pas de chimioth\u00e9rapie adjuvante<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>b. Tumeurs germinales du testicule avanc\u00e9es<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Tumeurs germinales s\u00e9minomateuses<\/li>\n<li>Stade IIA : radioth\u00e9rapie<\/li>\n<li>Stade IIB et diss\u00e9min\u00e9es : ne pas utiliser la Bl\u00e9omycine, G-CSF syst\u00e9matiques\n<ul>\n<li>Bon pronostic : 3 VIP<\/li>\n<li>Pronostic interm\u00e9diaire : 4 VIP<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\u00a0 \u00a0 Tumeurs germinales non s\u00e9minomateuses : ne pas utiliser la Bl\u00e9omycine, G-CSF syst\u00e9matiques<\/li>\n<li>Bon pronostic : 3 VIP<\/li>\n<li>Pronostic mauvais et interm\u00e9diaire : 4 VIP<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><u>R\u00e9f\u00e9rences:<\/u><\/p>\n<ul>\n<li style=\"text-align: justify;\">Russell B, Moss C, Rigg A, Van Hemelrijck M. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? 2020 Mar 30;14:1023.<\/li>\n<li style=\"text-align: justify;\">Fizazi K; pour les membres du bureau du Groupe d&rsquo;\u00e9tude des tumeurs uro-g\u00e9nitales. Therapeutic options for genitourinary cancers during the epidemic period of COVID-19.Bull Cancer. 2020 Mar 27.<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"ult-spacer spacer-69f410146fcf7\" data-id=\"69f410146fcf7\" data-height=\"35\" data-height-mobile=\"35\" data-height-tab=\"35\" data-height-tab-portrait=\"\" data-height-mobile-landscape=\"\" style=\"clear:both;display:block;\"><\/div><div class=\"g-cols wpb_row us_custom_60e9caca us_animate_this via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:3rem;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-text us_custom_7ccf62ca has_text_color\"><span class=\"w-text-h\"><span class=\"w-text-value\">PARTENAIRES<\/span><\/span><\/div><\/div><\/div><\/div><div class=\"w-image align_center\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"1300\" height=\"231\" src=\"https:\/\/onetech.dev\/covid\/data\/partenaire.png\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/onetech.dev\/covid\/data\/partenaire.png 1300w, https:\/\/onetech.dev\/covid\/data\/partenaire-300x53.png 300w, https:\/\/onetech.dev\/covid\/data\/partenaire-1024x182.png 1024w, https:\/\/onetech.dev\/covid\/data\/partenaire-150x27.png 150w\" sizes=\"auto, (max-width: 1300px) 100vw, 1300px\" \/><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"RECOMMANDATIONS G\u00c9N\u00c9RALES Urologique Retour1) Cancer de prostate a. Cancer de prostate localis\u00e9\u00a0 &#8211; Bas risque : surveillance active &#8211; Risque interm\u00e9diaire : Si indication de radioth\u00e9rapie : Strat\u00e9gie d\u2019attente par hormonoth\u00e9rapie n\u00e9o-adjuvante \u00e0 base d\u2019analogues LH-RH pendant 3 mois Si l\u2019hormonoth\u00e9rapie n\u00e9o-adjuvante a d\u00e9j\u00e0 \u00e9t\u00e9 administr\u00e9e : r\u00e9aliser une radioth\u00e9rapie hypofractionn\u00e9e (60 Gy en 20...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-150","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/onetech.dev\/covid\/wp-json\/wp\/v2\/pages\/150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onetech.dev\/covid\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/onetech.dev\/covid\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/onetech.dev\/covid\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onetech.dev\/covid\/wp-json\/wp\/v2\/comments?post=150"}],"version-history":[{"count":1,"href":"https:\/\/onetech.dev\/covid\/wp-json\/wp\/v2\/pages\/150\/revisions"}],"predecessor-version":[{"id":151,"href":"https:\/\/onetech.dev\/covid\/wp-json\/wp\/v2\/pages\/150\/revisions\/151"}],"wp:attachment":[{"href":"https:\/\/onetech.dev\/covid\/wp-json\/wp\/v2\/media?parent=150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}